Crypto Perpetuals Priced China's CXMT at $535 Billion Before Beijing Let Foreigners Buy a Single Share
ChangXin Memory Technologies begins trading on Shanghai’s STAR Market on Monday. A market for its shares has already existed for a week and a half — not in Shanghai, but on a decentralized derivatives exchange most of the company’s domestic subscribers have never heard of and cannot legally access.
Trade.xyz deployed a pre-IPO perpetual futures contract on Hyperliquid in mid-July, on the eve of subscriptions opening for what is Asia’s largest share sale of the year and the largest semiconductor offering ever run through China’s domestic A-share market. CXMT priced at 8.66 yuan, roughly $1.28, selling 6.69 billion shares for about 10 percent of the post-offering count and raising close to $8.6 billion. Within days the on-chain contract was trading near $8. Against a post-IPO share count of 66.881 billion, that implied a valuation around $535 billion — about 6.3 times what the underwriters had just settled on with institutional bookrunners in Shanghai.
The Access Asymmetry That Created the Trade
CXMT is not a speculative shell. It is China’s largest DRAM producer and the fourth-largest in the world by capacity, behind Samsung, SK Hynix, and Micron. DRAM is the bottleneck input for AI servers, and CXMT is the load-bearing element of Beijing’s plan to stop importing that bottleneck. A listing of this size on a market built explicitly as China’s answer to Nasdaq is one of the most consequential technology offerings anywhere this year.
Almost no foreign retail capital could touch it. Individual participation on the STAR Market generally requires 500,000 yuan in assets and two years of trading history, and the offering was overwhelmingly allocated onshore. Foreign institutions have quota-based channels; foreign individuals effectively do not. The result was an asymmetry that has been widening for years and became impossible to ignore this cycle: a globally significant asset, priced entirely by a domestic investor base, invisible to the capital that most wants exposure to it.
Beijing spent the first half of 2026 tightening in the opposite direction, cracking down on offshore brokerages that let mainland retail investors reach foreign markets and steering both listings and domestic capital toward Hong Kong as the controllable offshore venue. The controls are designed to govern where money enters and exits. What they do not govern is a synthetic contract priced by an oracle, settled in stablecoins, on infrastructure with no onshore presence to regulate.
What the Contract Is, and Is Not
The instrument is a perpetual future with no expiry, up to five times leverage, tracking the dollar value of one ordinary CXMT share. Holders receive no shares, no dividends, and no votes. It is a directional bet on a price, nothing more. Once Shanghai trading begins, the oracle converts the yuan-denominated quote into dollars at the prevailing rate.
It exists because Hyperliquid’s HIP-3 framework lets outside deployers stand up perpetual markets on assets that are not cryptocurrencies. Trade.xyz won the CXMT ticker at auction for 500 HYPE and has become the largest issuer of real-world-asset contracts on the venue, with earlier pre-IPO markets on SpaceX, Cerebras, and Quantinuum. CXMT is its first Chinese name. Since early July the venue’s prices have fed into mainstream charting terminals, which is a quieter but more significant development than any single listing: on-chain derivative quotes are now sitting in the same windows traders use for equities.
This is a different structure from tokenized equity. Ondo brought thirty-five tokenized US stocks and ETFs to HyperEVM in June, and those can be backed by custodied shares. A perpetual has no underlying holding and no redemption path, which means no arbitrage channel to the A-shares. Nothing forces the two prices to meet.
The Premium Measured Sentiment, Not Value
Read the numbers carefully and the $535 billion headline gets thinner. Early sessions ran around $1.3 million in daily volume against $2.4 million of open interest. Even at the frenzy’s peak, a day of $46.8 million in volume sat against roughly $21.8 million of open interest — enthusiastic longs on one side, a smaller cohort positioned for convergence on the other, and a headline valuation set by a very modest amount of capital. The contract has since drifted from its $8.60 high to around $6.35, still roughly five times the offer price and still implying a market capitalization above the upper bound of institutional estimates, which clustered between 2 and 3 trillion yuan.
The comparison to Trade.xyz’s own SpaceX contract is instructive. That one traded about 20 percent above its fixed offer price into the June debut. A 526 percent premium is not the same phenomenon at a larger scale; it is a market with no arbitrage discipline and very little capital deciding what it wants to believe.
Convergence Starts Monday
The interesting mechanics begin now. From the open in Shanghai, the perpetual stops being a poll about an unlisted company and starts tracking a live quote. STAR Market debutants trade without a daily price cap for their first five sessions before the standard 20 percent band applies, so the gap can close from below at speed — a violent first-day pop is entirely plausible for a name this heavily oversubscribed and this politically freighted. Whether it closes far enough to validate a five-fold premium is a separate question, and the funding rate has been paying for the answer either way.
The Jurisdictional Gap Is the Product
The uncomfortable part, for regulators on both ends, is that nobody in this structure is doing anything about it. Hyperliquid restricts US users and is not available in China. Singapore’s monetary authority added the platform to its Investor Alert List in June, which is a notice of non-authorization rather than an enforcement action. Trade.xyz and Hyperliquid’s policy arm have been meeting the SEC’s crypto task force, where the agenda is American compliance; Chinese asset exposure is not on the list of anyone’s stated concerns.
So the contract sits in the space between three regulators, offering the one thing capital controls are specifically built to prevent: price discovery on a domestic asset by foreign money that was never granted admission. Beijing can restrict who buys shares. It has no mechanism to restrict who quotes them.
That is the story worth watching past Monday’s convergence. CXMT is a test case, not an endpoint. If the pattern holds — a marquee onshore listing, a synthetic offshore market spun up days ahead of it, prices piped into terminals where institutional traders already live — then the next politically sensitive Chinese IPO will get shadow-priced by strangers before the bookrunners finish their calls. The premium will compress as these markets deepen and as convergence trades get better funded. The access channel will not close.